Preferential suppression of delayed-type hypersensitivity by L-156,602, a C5a receptor antagonist

Biosci Biotechnol Biochem. 1992 Oct;56(10):1686-9. doi: 10.1271/bbb.56.1686.

Abstract

In the course of our screening for in vivo immunomodulating substances in which sheep red blood cells (SRBC) and heat-killed Brucella abortus cells (thymus dependent and independent antigens, respectively) for antibody production assays, and trinitrobenzene sulfonic acid (TNBS) for delayed-type hypersensitivity (DTH) assay were adopted as antigens, we detected a DTH-specific suppressive activity. The producing organism was isolated from a soil sample collected in Ushiku City, Ibaraki, Japan and identified with Streptomyces sp. A1502 (FERM P-12448). The active component was identified with L-156,602, a C5a receptor antagonist. L-156,602 suppressed both TNBS-induced and TNP-SRBC-induced DTH while it enhanced antibody production against SRBC, Brucella abortus, and TNP-SRBC. L-156,602 significantly suppressed DTH induced by direct injection of type 1 helper T cells and its relevant antigen into hind-footpads, indicating that the efferent phase of DTH was affected by L-156,602. The results demonstrated that L-156,602 preferentially suppressed the DTH response.

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • Antibody Formation / drug effects
  • Brucella Vaccine / pharmacology
  • Brucella abortus / immunology
  • Complement C5a / antagonists & inhibitors*
  • Erythrocytes / drug effects
  • Female
  • Hypersensitivity, Delayed / drug therapy*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Peptides, Cyclic / biosynthesis
  • Peptides, Cyclic / isolation & purification
  • Peptides, Cyclic / pharmacology*
  • Sheep
  • Streptomyces / chemistry
  • Streptomyces / classification
  • Streptomyces / metabolism

Substances

  • Adjuvants, Immunologic
  • Brucella Vaccine
  • Peptides, Cyclic
  • PD 124966
  • Complement C5a